1. World Health Organization. WHO guidelines for safe surgery 2009. Geneva. WHO Press. 2009.
2. 日本手術医学会. 手術医療の実践ガイドライン(改訂版). 手術医学 34:supplement, 2013.
3. Berríos-Torres SI, Umscheid CA, Bratzler DW, Leas B, Stone EC, Kelz RR, Reinke CE, Morgan S, Solomkin JS, Mazuski JE, Dellinger EP, Itani KMF, Berbari EF, Segreti J, Parvizi J, Blanchard J, Allen G, Kluytmans JAJW, Donlan R, Schecter WP; Healthcare Infection Control Practices Advisory Committee. Centers for Disease Control and Prevention Guideline for the Prevention of Surgical Site Infection, 2017. JAMA Surg 152:784-791, 2017.
4. World Health Organization. Global guidelines for the prevention of surgical site infection. WHO Document Production Services. 2016.
5. Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for Prevention of Surgical Site Infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee. Am J Infect Control 27:97-132, 1999.
6. 岩井重富. 手術後の合併症とその処置. 外科学. 233-242. 東京. 南江堂. 2002.
7. Naumann MG, Sigurdsen U, Utvåg SE, Stavem K. Functional outcomes following surgical-site infections after operative fixation of closed ankle fractures. Foot Ankle Surg 23:311-316, 2017.
8. Kuy S, Dua A, Desai S, Dua A, Patel B, Tondravi N, Seabrook GR, Brown KR, Lewis BD, Lee CJ, Kuy S, Subbarayan R, Rossi PJ. Surgical site infections after lower extremity revascularization procedures involving groin incisions. Ann Vasc Surg 28:53- 58, 2014.
9. Schweizer ML, Cullen JJ, Perencevich EN, Vaughan Sarrazin MS. Costs Associated With Surgical Site Infections in Veterans Affairs Hospitals. JAMA Surg 149:575-581, 2014.
10. Badia JM, Casey AL, Petrosillo N, Hudson PM, Mitchell SA, Crosby C. Impact of surgical site infection on healthcare costs and patient outcomes: a systematic review in six European countries. J Hosp Infect 96:1-15, 2017.
11. Coello R, Charlett A, Wilson J, Ward V, Pearson A, Borriello P. Adverse impact of surgical site infections in English hospitals. J Hosp Infect 60:93-103, 2005.
12. de Lissovoy G, Fraeman K, Hutchins V, Murphy D, Song D, Vaughn BB. Surgical site infection: incidence and impact on hospital utilization and treatment costs. Am J Infect Control 37:387-397, 2009.
13. Jenks PJ, Laurent M, McQuarry S, Watkins R. Clinical and economic burden of surgical site infection (SSI) and predicted financial consequences of elimination of SSI from an English hospital. J hosp infect 86:24–33, 2014.
14. Umscheid CA, Mitchell MD, Doshi JA, Agarwal R, Williams K, Brennan PJ. Estimating the proportion of healthcare-associated infections that are reasonably preventable and the related mortality and costs. Infect Control Hosp Epidemiol 32:101-114, 2011.
15. Ban KA, Minei JP, Laronga C, Harbrecht BG, Jensen EH, Fry DE, Itani KM, Dellinger EP, Ko CY, Duane TM. American College of Surgeons and Surgical Infection Society: Surgical Site Infection Guidelines, 2016 Update. J Am Coll Surg 224:59-74, 2017.
16. Liu Z, Dumville JC, Norman G, Westby MJ, Blazeby J, McFarlane E, Welton NJ, O'Connor L, Cawthorne J, George RP, Crosbie EJ, Rithalia AD, Cheng HY. Intraoperative interventions for preventing surgical site infection: an overview of Cochrane Reviews. Cochrane Database Syst Rev 2:CD012653, 2018.
17. Donabedian A. Evaluating the quality of medical care. Milbank Mem Fund Q 44:166- 206, 1966.
18. Rutala WA, Gergen MF, Jones JF, Weber DJ. Levels of microbial contamination on surgical instruments. Am J Infect Control 26:143-145, 1998.
19. Chan-Myers H, McAlister D, Antonoplos P. Natural bioburden levels detected on rigid lumened medical devices before and after cleaning. Am J Infect Control 25:471-476, 1997.
20. Chu NS, Chan-Myers H, Ghazanfari N, Antonoplos P. Levels of naturally occurring microorganisms on surgical instruments after clinical use and after washing. Am J Infect Control 27:315-319, 1999.
21. Nyström B. Disinfection of surgical instruments. J Hosp Infect 2:363-368, 1981.
22. Pinto FMG, Souza RQ, Silva CB, Mimica LMJ, Graziano KU. Analysis of the microbial load in instruments used in orthopedic surgeries. Am J Infect Control 38:229-233, 2010.
23. Saito Y, Kobayashi H, Uetera Y, Yasuhara H, Kajiura T, Okubo T. Microbial contamination of surgical instruments used for laparotomy. Am J Infect Control 42:43-47, 2014.
24. Patrick S, McDowell A, Lee A, Frau A, Martin U, Gardner E, McLorinan G, Eames N. Antisepsis of the skin before spinal surgery with povidone iodine-alcohol followed by chlorhexidine gluconate-alcohol versus povidone iodine-alcohol applied twice for the prevention of contamination of the wound by bacteria: a randomised controlled trial. Bone Joint J 99-B:1354-1365, 2017.
25. Guzel A, Ozekinci T, Ozkan U, Celik Y, Ceviz A, Belen D. Evaluation of the skin flora after chlorhexidine and povidone-iodine preparation in neurosurgical practice. Surg Neurol 71:207-210, 2009.
26. Schardey HM, Joosten U, Finke U, Staubach KH, Schauer R, Heiss A, Kooistra A, Rau HG, Nibler R, Lüdeling S, Unertl K, Ruckdeschel G, Exner H, Schildberg FW. The prevention of anastomotic leakage after total gastrectomy with local decontamination. A prospective, randomized, double-blind, placebo-controlled multicenter trial. Ann Surg 225:172-180, 1997.
27. Sugiura T, Mizuno T, Okamura Y, Ito T, Yamamoto Y, Kawamura I, Kurai H, Uesaka K. Impact of bacterial contamination of the abdominal cavity during pancreaticoduodenectomy on surgical-site infection. Br J Surg 102:1561-1566, 2015.
28. Dumville JC, McFarlane E, Edwards P, Lipp A, Holmes A, Liu Z. Preoperative skin antiseptics for preventing surgical wound infections after clean surgery. Cochrane Database Syst Rev 4:CD003949, 2015.
29. Nayuni NK, Cloutman-Green E, Hollis M, Hartley J, Martin S, Perrett D. Critical evaluation of ninhydrin for monitoring surgical instrument decontamination. J Hosp Infect 84:97-102, 2013.
30. Hashimoto D, Chikamoto A, Arima K, Taki K, Inoue R, Imai K, Yamashita Y, Baba H. Unused sterile instruments for closure prevent wound surgical site infection after pancreatic surgery. J Surg Res 205:38-42, 2016.
31. Wilson SE. Microbial sealing: a new approach to reducing contamination. J Hosp Infect 70 Suppl 2:11-4, 2008.
32. Wehrl M, Michels W. A method for testing the cleaning of MIS robotic instruments. Central Service 3:202-207, 2013.
33. Saito Y, Yasuhara H, Murakoshi S, Komatsu T, Fukatsu K, Uetera Y. Challenging Residual Contamination of Instruments for Robotic Surgery in Japan. Infect Control Hosp Epidemiol 38:143-146, 2017.
34. 日本医療機器学会. 洗浄評価判定ガイドライン. 東京. 一般社団法人日本医療機 器学会. 2012.
35. Lucas AD, Nagaraja S, Gordon EA, Hitchins VM. Evaluating device design and cleanability of orthopedic device models contaminated with a clinically relevant bone test soil. Biomed Instrum Technol 49:354–362, 2015.
36. Otter JA, Yezli S, French GL. The role played by contaminated surfaces in the transmission of nosocomial pathogens. Infect Control Hosp Epidemiol 32:687-699, 2011.
37. Weber DJ, Rutala WA, Miller MB, Huslage K, Sickbert-Bennett E. Role of hospital surfaces in the transmission of emerging health care-associated pathogens: norovirus, Clostridium difficile, and Acinetobacter species. Am J Infect Control 38:S25-S33, 2010.
38. Boyce JM. Environmental contamination makes an important contribution to hospital infection. J Hosp Infect 65:50-54, 2007.
39. Weber DJ, Anderson D, Rutala WA. The role of the surface environment in healthcareassociated infections. Curr Opin Infect Dis 26:338-344, 2013.
40. Vianna PG, Dale CR Jr, Simmons S, Stibich M, Licitra CM. Impact of pulsed xenon ultraviolet light on hospital-acquired infection rates in a community hospital. Am J Infect Control 44:299-303, 2016.
41. Jinadatha C, Quezada R, Huber TW, Williams JB, Zeber JE, Copeland LA. Evaluation of a pulsed-xenon ultraviolet room disinfection device for impact on contamination levels of methicillin-resistant Staphylococcus aureus. BMC Infect Dis 14:187, 2014.
42. Weber DJ, Kanamori H, Rutala WA. 'No touch' technologies for environmental decontamination: focus on ultraviolet devices and hydrogen peroxide systems. Curr Opin Infect Dis 29:424-431, 2016.
43. Weber DJ, Rutala WA, Anderson DJ, Chen LF, Sickbert-Bennett EE, Boyce JM. Effectiveness of ultraviolet devices and hydrogen peroxide systems for terminal room decontamination: Focus on clinical trials. Am J Infect Control 44:e77-e84, 2016.
44. Meakin NS, Bowman C, Lewis MR, Dancer SJ. Comparison of cleaning efficacy between in-use disinfectant and electrolysed water in an English residential care home. J Hosp Infect 80:122-127, 2012.
45. Smith DL, Gillanders S, Holah JT, Gush C. Assessing the efficacy of different microfibre cloths at removing surface micro-organisms associated with healthcare-associated infections. J Hosp Infect 78:182-186, 2011.
46. Sehulster L, Chinn RY; CDC; HICPAC. Guidelines for environmental infection control in health-care facilities. Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC). MMWR Recomm Rep 52(RR-10):1-42, 2003.
47. Saito Y, Yasuhara H, Murakoshi S, Komatsu T, Fukatsu K, Uetera Y. Time-dependent influence on assessment of contaminated environmental surfaces in operating rooms. Am J Infect Control 43:951-955, 2015.
48. Shama G, Malik DJ. The uses and abuses of rapid bioluminescence-based ATP assays. Int J Hyg Environ Health 216:115-25, 2013.
49. Michels W, Roth K, Eibl R. Assessment of cleaning efficacy based on the protein-surface relationship. Central Service 3:212-215, 2013.
50. Carter A, Krüger S, Schmidt V, Bobyk D, Eibl, R, Heeg P, Held M,Jones A, Kober P, Kramer A, Linner M, Martiny H, Michels W, Roth K, Schwarzer H, Weitze W, Werner H. Guideline compiled by the DGKH, DGSV and AKI for validation and routine monitoring of automated cleaning and disinfection processes for heat-resistant medical devices as well as advice on selecting washer-disinfectors. Central Service 15:1-48, 2007.
51. Southworth PM. Infections and exposures: reported incidents associated with unsuccessful decontamination of reusable surgical instruments. J Hosp Infect 88:127-131, 2014.
52. Cooper RA, Griffith CJ, Malik RE, Obee P, Looker N. Monitoring the effectiveness of cleaning in four British hospitals. Am J Infect Control 35:338-341, 2007.
53. Griffith CJ, Cooper RA, Gilmore J, Davies C, Lewis M. An evaluation of hospital cleaning regimes and standards. J Hosp Infect 45:19-28, 2000.
54. Griffith CJ, Obee P, Cooper RA, Burton NF, Lewis M. The effectiveness of existing and modified cleaning regimens in a Welsh hospital. J Hosp Infect 66:352-359, 2007.
55. Lei H, Jones RM, Li Y. Exploring surface cleaning strategies in hospital to prevent contact transmission of methicillin-resistant Staphylococcus aureus. BMC Infect Dis 17:85, 2017.
56. Goodman ER, Platt R, Bass R, Onderdonk AB, Yokoe DS, Huang SS. Impact of an environmental cleaning intervention on the presence of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci on surfaces in intensive care unit rooms. Infect Control Hosp Epidemiol 29:593-599, 2008.
57. Dancer SJ. Importance of the environment in meticillin-resistant Staphylococcus aureus acquisition: the case for hospital cleaning. Lancet Infect Dis 8:101-113, 2008.
58. Stulberg JJ, Delaney CP, Neuhauser DV, Aron DC, Fu P, Koroukian SM. Adherence to Surgical Care Improvement Project measures and the association with postoperative infections. JAMA 303:2479-2485, 2010.
59. Tillman M, Wehbe-Janek H, Hodges B, Smythe WR, Papaconstantinou HT. Surgical Care Improvement Project and surgical site infections: can integration in the surgical safety checklist improve quality performance and clinical outcomes? J Surg Res 184:150- 156, 2013.
60. Cataife G, Weinberg DA, Wong HH, Kahn KL. The effect of Surgical Care Improvement Project (SCIP) compliance on surgical site infections (SSI). Med Care 52:S66-S73, 2014.
61. Ng WK, Awad N. Performance improvement initiative: prevention of surgical site infection (SSI). BMJ Qual Improv Rep 4, 2015.